KORU Medical reports record Q4 revenue $8.9M (+23% YoY); positive cash flow in Q4

KORU Medical Systems, Inc.

2024-FY EPS reported -$0.13 revenue$33,646,463

Preliminary full-year 2024 net revenue of $33.7M, up 18% YoY; Q4 revenue $8.9M, up 23% YoY.
Ending cash balance $9.6M; Q4 generated positive cash flow of $0.8M.
Full-year cash burn $1.9M, a 67% improvement over prior year.
CEO cites U.S. market share gains, international expansion, and progress on new drug therapy labeling.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.